half 40 patients given berzosertib growth tumors halted berzosertib effective given alongside chemotherapy trial run institute cancer research icr royal marsden nhs trust suggested trial designed test safety drug drug trialed new family treatments block protein involved dna repair blocking protein prevents cancers mending damage cells branch treatment known precision medicine targets specific genes genetic changes study involved patients advanced tumors treatment worked known phase trial designed test safety treatment icr said researchers find early indications berzosertib stop tumors growing study authors prof chris lord professor cancer genomics icr said early signs promising adding unusual phase trials clinical response trials